Recent Developments in Texaphyrin Chemistry and Drug Discovery

被引:63
作者
Preihs, Christian [1 ]
Arambula, Jonathan F. [1 ,4 ]
Magda, Darren [2 ]
Jeong, Heeyeong [3 ]
Yoo, Dongwon [3 ]
Cheon, Jinwoo [3 ]
Siddik, Zahid H. [4 ]
Sessler, Jonathan L. [1 ,3 ]
机构
[1] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA
[2] Lumiphore Inc, Richmond, CA 94804 USA
[3] Yonsei Univ, Dept Chem, Seoul 120749, South Korea
[4] UT MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA
基金
新加坡国家研究基金会;
关键词
MOTEXAFIN GADOLINIUM; PHOTODYNAMIC THERAPY; EXPANDED PORPHYRINS; MONOCLONAL-ANTIBODY; BRAIN METASTASES; METAL-COMPLEXES; CISPLATIN; RADIATION; P53; CANCER;
D O I
10.1021/ic400226g
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
Texaphyrins are pentaaza expanded porphyrins with the ability to form stable complexes with a variety of metal cations, particularly those of the lanthanide series. In biological milieus, texaphyrins act as redox mediators and mediate the production of reactive oxygen species (ROS). In this review, newer studies involving texaphyrin complexes targeting several different applications in anticancer therapy are described. In particular, the preparation of bismuth and lead texaphyrin complexes as potential alpha-core emitters for radiotherapy is detailed, as are gadolinium texaphyrin functionalized magnetic nanoparticles with features that make them of interest as dual-mode magnetic resonance imaging contrast agents and as constructs with anticancer activity mediated through ROS-induced sensitization and concurrent hyperthermia. Also discussed are gadolinium texaphyrin complexes as possible carrier systems for the targeted delivery of platinum payloads.
引用
收藏
页码:12184 / 12192
页数:9
相关论文
共 69 条
[1]   A BINUCLEATING ACCORDIAN TETRAPYRROLE MACROCYCLE [J].
ACHOLLA, FV ;
MERTES, KB .
TETRAHEDRON LETTERS, 1984, 25 (31) :3269-3270
[2]   BINUCLEATING TETRAPYRROLE MACROCYCLES [J].
ACHOLLA, FV ;
TAKUSAGAWA, F ;
MERTES, KB .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1985, 107 (24) :6902-6908
[3]   A texaphyrin-oxaliplatin conjugate that overcomes both pharmacologic and molecular mechanisms of cisplatin resistance in cancer cells [J].
Arambula, Jonathan F. ;
Sessler, Jonathan L. ;
Siddik, Zahid H. .
MEDCHEMCOMM, 2012, 3 (10) :1275-1281
[4]  
Arambula JF, 2011, ANTI-CANCER AGENT ME, V11, P222
[5]   Overcoming biochemical pharmacologic mechanisms of platinum resistance with a texaphyrin-platinum conjugate [J].
Arambula, Jonathan F. ;
Sessler, Jonathan L. ;
Siddik, Zahid H. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (06) :1701-1705
[6]   Gadolinium texaphyrin (Gd-Tex)-malonato-platinum conjugates: Synthesis and comparison with carboplatin in normal and Pt-resistant cell lines [J].
Arambula, Jonathan F. ;
Sessler, Jonathan L. ;
Fountain, Mark E. ;
Wei, Wen-hao ;
Magda, Darren ;
Siddik, Zahid H. .
DALTON TRANSACTIONS, 2009, (48) :10834-10840
[7]   Cellular magnetic resonance imaging: current status and future prospects [J].
Arbab, Ali S. ;
Liu, Wei ;
Frank, Joseph A. .
EXPERT REVIEW OF MEDICAL DEVICES, 2006, 3 (04) :427-439
[8]   Synthesis of a boronic ester-appended bismuth(III) porphyrin as a potential alpha-particle bi-emitter [J].
Balieu, Sebastien ;
Bouraiou, Abdel Malek ;
Carboni, Bertrand ;
Boitrel, Bernard .
JOURNAL OF PORPHYRINS AND PHTHALOCYANINES, 2008, 12 (01) :11-18
[9]   Bismuth porphyrin complexes: syntheses and structural studies [J].
Boitrel, B ;
Breede, M ;
Brothers, PJ ;
Hodgson, M ;
Michaudet, L ;
Rickard, CEF ;
Al Salim, N .
DALTON TRANSACTIONS, 2003, (09) :1803-1807
[10]  
Bosl G.J., 2001, CANC TESTIS